Global CGT CDMO Competitive Landscape Professional Research Report 2025
Research Summary
A CGT CDMO (Contract Development and Manufacturing Organization for Cell and Gene Therapy) is a specialized service provider that supports the biopharmaceutical industry by offering comprehensive development and manufacturing solutions for cell and gene therapies. These organizations facilitate every stage of the therapy development process, from research and development to clinical trial material production, regulatory compliance, and large-scale commercial manufacturing. By leveraging advanced facilities, expert personnel, and regulatory expertise, CGT CDMOs enable biotech and pharmaceutical companies to accelerate the development and commercialization of innovative treatments. This allows companies to focus on their core competencies while ensuring efficient, high-quality production and adherence to regulatory standards, ultimately speeding up the delivery of advanced therapies to patients.
According to DIResearch's in-depth investigation and research, the global CGT CDMO market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of CGT CDMO include WuXi AppTec, OBiO, GenScript, Porton, Lonza, Pharmaron, Catalent, Thermo Fisher, Oxford Biomedica (OXB), Asymchem, Rentschler Biopharma, Novartis etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CGT CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CGT CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CGT CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CGT CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of CGT CDMO Include:
WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis
CGT CDMO Product Segment Include:
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA
CGT CDMO Product Application Include:
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global CGT CDMO Industry PESTEL Analysis
Chapter 3: Global CGT CDMO Industry Porter’s Five Forces Analysis
Chapter 4: Global CGT CDMO Major Regional Market Size and Forecast Analysis
Chapter 5: Global CGT CDMO Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global CGT CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 CGT CDMO Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CGT CDMO Product by Type
- 1.2.1 Immune Cells
- 1.2.2 Stem Cells
- 1.2.3 Viral Vectors
- 1.2.4 Plasmid DNA
- 1.3 CGT CDMO Product by Application
- 1.3.1 Pharmaceutical and Biotechnology Companies
- 1.3.2 Research and Academic Institutions
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global CGT CDMO Market Size Analysis (2020-2032)
- 1.5 CGT CDMO Market Development Status and Trends
- 1.5.1 CGT CDMO Industry Development Status Analysis
- 1.5.2 CGT CDMO Industry Development Trends Analysis
- 2 CGT CDMO Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CGT CDMO Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CGT CDMO Market Analysis by Regions
- 4.1 CGT CDMO Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global CGT CDMO Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global CGT CDMO Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global CGT CDMO Revenue Forecast by Region (2026-2032)
- 5 Global CGT CDMO Market Size by Type and Application
- 5.1 Global CGT CDMO Market Size by Type (2020-2032)
- 5.2 Global CGT CDMO Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America CGT CDMO Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America CGT CDMO Market Size by Type
- 6.4 North America CGT CDMO Market Size by Application
- 6.5 North America CGT CDMO Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe CGT CDMO Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe CGT CDMO Market Size by Type
- 7.4 Europe CGT CDMO Market Size by Application
- 7.5 Europe CGT CDMO Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China CGT CDMO Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China CGT CDMO Market Size by Type
- 8.4 China CGT CDMO Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) CGT CDMO Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) CGT CDMO Market Size by Type
- 9.4 APAC (excl. China) CGT CDMO Market Size by Application
- 9.5 APAC (excl. China) CGT CDMO Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America CGT CDMO Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America CGT CDMO Market Size by Type
- 10.4 Latin America CGT CDMO Market Size by Application
- 10.5 Latin America CGT CDMO Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa CGT CDMO Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa CGT CDMO Market Size by Type
- 11.4 Middle East & Africa CGT CDMO Market Size by Application
- 11.5 Middle East & Africa CGT CDMO Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global CGT CDMO Market Revenue by Key Manufacturers (2021-2025)
- 12.2 CGT CDMO Competitive Landscape Analysis and Market Dynamic
- 12.2.1 CGT CDMO Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 WuXi AppTec
- 13.1.1 WuXi AppTec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 WuXi AppTec CGT CDMO Product Portfolio
- 13.1.3 WuXi AppTec CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 OBiO
- 13.2.1 OBiO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 OBiO CGT CDMO Product Portfolio
- 13.2.3 OBiO CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 GenScript
- 13.3.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 GenScript CGT CDMO Product Portfolio
- 13.3.3 GenScript CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Porton
- 13.4.1 Porton Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Porton CGT CDMO Product Portfolio
- 13.4.3 Porton CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Lonza
- 13.5.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Lonza CGT CDMO Product Portfolio
- 13.5.3 Lonza CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Pharmaron
- 13.6.1 Pharmaron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Pharmaron CGT CDMO Product Portfolio
- 13.6.3 Pharmaron CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Catalent
- 13.7.1 Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Catalent CGT CDMO Product Portfolio
- 13.7.3 Catalent CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Thermo Fisher
- 13.8.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Thermo Fisher CGT CDMO Product Portfolio
- 13.8.3 Thermo Fisher CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Oxford Biomedica (OXB)
- 13.9.1 Oxford Biomedica (OXB) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Oxford Biomedica (OXB) CGT CDMO Product Portfolio
- 13.9.3 Oxford Biomedica (OXB) CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Asymchem
- 13.10.1 Asymchem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Asymchem CGT CDMO Product Portfolio
- 13.10.3 Asymchem CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Rentschler Biopharma
- 13.11.1 Rentschler Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Rentschler Biopharma CGT CDMO Product Portfolio
- 13.11.3 Rentschler Biopharma CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Novartis
- 13.12.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Novartis CGT CDMO Product Portfolio
- 13.12.3 Novartis CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 CGT CDMO Industry Chain Analysis
- 14.2 CGT CDMO Industry Raw Material and Suppliers Analysis
- 14.2.1 CGT CDMO Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 CGT CDMO Typical Downstream Customers
- 14.4 CGT CDMO Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook